Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 17.202% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a Cc1nn(-c2ccccc2)c(C)c1C(=O)OC/C(O)=C(\C#N)c1nc2ccccc2[nH]1
b c1ccn2cc(C34CC5CC(CC(C5)C3)C4)nc2c1
c N#CCC(=O)N1CCn2c1nc1ccccc12
d CC(C(=O)NCc1ccc2c(c1)OCO2)N(c1ccccc1)S(C)(=O)=O
Answer: c. N#CCC(=O)N1CCn2c1nc1ccccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#CCC(=O)N1CCn2c1nc1ccccc12
N#CCC(=O)N1CCn2c1nc1ccccc12
3-(1,2-dihydroimidazo[1,2-a]benzimidazol-3-yl)-3-oxopropanenitrile